Product Images Na

The text describes a chart or table that shows the percentage of patients who improved after taking certain medications and a placebo. The medications listed are Duloctine Gomg 8D, Oulosetne60mg QD, and T oulosetne 20mg Q0. The chart also shows the percentage improvement in pain from the baseline.*

The text describes a chart or graph that displays the percentage of patients improved, with a placebo and Duloxetine 60/120 mg once daily. The chart also shows the percentage improvement in pain from baseline. There are percentages ranging from 10 to 100%.*

The text provides data related to the percentage of improvement in patients who took Duloxetine 60 mg daily compared to those who took a placebo. The graph also shows the percentage of pain improvement from a baseline.*

The text provides a graph showing the percentage of patients' improvement in pain from baseline while using placebo and Duloxetine (60/120mg). The X-axis ranges from 210 to 290, and the Y-axis represents the percentage of improvement ranging from 0 to 100. It is not possible to determine what is being treated or the duration of the treatment.*

This is the label of Duloxetine, Delayed-Release Capsules, USP containing 60 capsules, manufactured by Qingdao BAHEAL Pharmaceutical Co., Ltd. It is prescribed medication and the pharmacist is advised to dispense the medication guide to each patient. Each capsule contains 22.4 myg of Duloxetine hydrochloride, USP equivalent to 20 mg Duloxetine. The recommended storage temperature is between 20° to 25°C (68° to 77°F), and it should be tightly closed, kept out of reach of children. Usual dosage information is available in the accompanying literature. Revised in August 2018.*

This is a label for a medication called Duloxetine. It contains delayed-release capsules which each have 33.7 myg of duloxetine hydrochloride, USP equivalent to 30 mg duloxetine. The medication is intended for use under prescription and comes in a tightly closed container. It is manufactured in China by Qingdao BAHEAL Pharmaceutical Co., Ltd. The label recommends storing the medication at 20° to 25°C (68° to 77°F), and the expiring date is indicated as 3 074/Exp. The dosage information is provided in the accompanying literature. The pharmacist is directed to dispense the Medication Guide separately with each patient.*

This text is a description of a medication called Duloxetine which is a delayed-release capsule used to treat various conditions. Each capsule contains 33.7 mg of duloxetine hydrochloride, equivalent to 30 mg duloxetine. Consumers are advised to be given the medication guide provided separately by the pharmacist. The medication is stored at temperatures between 20-25°C and tightly closed containers to be used to prevent harm to children. The manufacturer of the medication is Qingdao BAHEAL Pharmaceutical Co., Ltd.*

This is a medication with the brand name Duloxetine, available in the form of delayed-release capsules. It contains 33.7 mg of duloxetine hydrochloride, which is equivalent to 30 mg of duloxetine. The medication comes in a container with 90 capsules, and each patient is supposed to receive a Medication Guide when it is dispensed. The medication should be stored in a tightly closed container at a controlled room temperature. The recommended dosage should be taken as per the accompanying literature. The medication is manufactured by Qingdao BAHEAL Pharmacettical Co., Ltd., located in Qingdao, Shandong, China. The information was revised in August 2018.*

This is the label of Duloxetine Delayed-Release Capsules, USP containing 30 capsules with each capsule containing 67.3 myg of duloxetine hydrochloride and equivalent to 60 mg duloxetine. The medication guide should be dispensed separately to each patient. It is advisable to store the product at 20° to 25°C (68° to 77°F) and in a tightly closed container, out of reach of children. The dosage information can be found in the accompanying literature. The medication is manufactured by Qingdao BAHEAL Pharmacettical Co., Ltd. in China.*

This text is a description of a medication called Duloxetine. It comes in a delayed-release capsule with a strength of 60mg. The medication contains duloxetine hydrochloride and must be stored at a temperature of 20° to 25°C. The medication guide provided separately by the pharmacist should be given to each patient. The usual dosage should be determined by accompanying literature. This medication is manufactured by Qingdao BAHEAL Pharmaceutical Co., Ltd in China. The text also includes details of product code, expiry date, and precautions for storage and dispensing.*

This is a description of Duloxetine Delayed-Release Capsules, USP, dosage 60mg. Each capsule contains 67.3mg of duloxetine hydrochloride, USP equivalent to 60mg duloxetine. The pharmacist has to dispense the Medication Guide separately to every patient. The capsules should be stored at 20° to 25°C (68° to 77°F), with excursions allowed to 15° to 30°C (59° to 86°F). The medication should be dispensed in a tightly closed container and kept out of reach of children. The usual dosage can be found in the accompanying literature. The medications are produced by Qingdao BAHEAL Pharmaceutical Co., Ltd. in Qingdao, Shandong, China. The lot number of the batch is "3 70247 01406 || 2". The text on the side panel is not available.*